Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition
- PMID: 7171570
- DOI: 10.1021/bi00265a018
Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition
Abstract
The interaction between factor Xa and factor Va was investigated both in solution and in the presence of phospholipid vesicles with varying contents of phosphatidylserine. The binding parameters were inferred from the kinetics of prothrombin activation. Factor Xa and factor Va form in solution an equimolar complex with a dissociation constant of 3.3 X 10(-9) M. Phospholipid vesicles promote the formation of the factor Xa-Va complex. The Kd of complex formation is dependent on both the phospholipid concentration and the composition of the phospholipid vesicle. For the interaction between factor Xa and factor Va in the presence of phospholipid vesicles containing 40 mol % dioleoylphosphatidylserine (DOPS) and 60 mol % dioleoylphosphatidylcholine (DOPC), the Kd increases linearly with increasing phospholipid concentration. In the presence of 10 microM phospholipid (DOPS/DOPC, 40/60 mol/mol) Kd = 3 X 10(-11) M. When the mole percentage of DOPS in the phospholipid vesicles is lowered from 20 to 5 mol %, there is a gradual increase of the Kd. In the presence of 10 microM phospholipid vesicles containing 5 mol % DOPS and 95 mol % DOPC Kd = 2.8 X 10(-10) M. The Kd measured in the presence of phospholipid vesicles containing 5 mol % DOPS and 95 mol % DOPC is independent of the phospholipid concentration. Two models are discussed that can quantitatively explain the effect of phospholipid vesicles on the complex formation between factor Xa and factor Va. Studies on the effect of the polypeptides with Mr 80 000 and Mr 94000 of which factor Va is composed on the Kd of the factor Xa-Va complex suggest that factor Xa binding to factor Va requires a Ca2+-mediated interaction between the two polypeptides.
Similar articles
-
Interaction of prothrombin with factor Va-phospholipid complexes.Biochemistry. 1984 Jun 5;23(12):2838-42. doi: 10.1021/bi00307a047. Biochemistry. 1984. PMID: 6466619
-
The role of phospholipids and factor Va in the prothrombinase complex.J Biol Chem. 1980 Jan 10;255(1):274-83. J Biol Chem. 1980. PMID: 7350159
-
Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex.Biochemistry. 1984 Sep 25;23(20):4557-64. doi: 10.1021/bi00315a008. Biochemistry. 1984. PMID: 6498156
-
Factor X.Prog Hemost Thromb. 1984;7:55-109. Prog Hemost Thromb. 1984. PMID: 6397768 Review. No abstract available.
-
Factor V.Methods Enzymol. 1981;80 Pt C:249-74. doi: 10.1016/s0076-6879(81)80023-7. Methods Enzymol. 1981. PMID: 7043191 Review. No abstract available.
Cited by
-
Fibrinolysis in Platelet Thrombi.Int J Mol Sci. 2021 May 12;22(10):5135. doi: 10.3390/ijms22105135. Int J Mol Sci. 2021. PMID: 34066261 Free PMC article. Review.
-
Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.PLoS Comput Biol. 2010 Sep 30;6(9):e1000950. doi: 10.1371/journal.pcbi.1000950. PLoS Comput Biol. 2010. PMID: 20941387 Free PMC article.
-
Cryo-EM structure of the prothrombin-prothrombinase complex.Blood. 2022 Jun 16;139(24):3463-3473. doi: 10.1182/blood.2022015807. Blood. 2022. PMID: 35427420 Free PMC article.
-
Complete cDNA and derived amino acid sequence of human factor V.Proc Natl Acad Sci U S A. 1987 Jul;84(14):4846-50. doi: 10.1073/pnas.84.14.4846. Proc Natl Acad Sci U S A. 1987. PMID: 3110773 Free PMC article.
-
Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):33-7. doi: 10.1042/bj3230033. Biochem J. 1997. PMID: 9173898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous